First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued (TRAXV) — Defensive Interval Ratio
First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued (TRAXV) has a Defensive Interval Ratio of 2646 days as of December 2024. Defensive assets of $262.29 Million (cash $-, short-term investments $262.29 Million, receivables $-) cover 2646 days of daily cash needs of $99.13K/day. Check tangible net worth ratio of First Tracks Biotherapeutics, Inc. Ordin to evaluate the tangible quality of the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued Defensive Interval Ratio (2023–2024)
This chart shows how First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued's Defensive Interval Ratio has evolved across 2 annual periods from 2023 to 2024. As of December 2024, the ratio stands at 2646 days, meaning defensive assets of $262.29 Million can fund 2646 days of operations without new revenue. Also explore TRAXV net asset momentum to track the company's year-over-year net asset growth rate.
Annual Defensive Interval Ratio for First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued (2023–2024)
The table below presents the year-by-year Defensive Interval Ratio for First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued from 2023 to 2024, covering 2 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see TRAXV stock market capitalisation.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2024 | 2646 days | $262.29 Million | $99.13K/day | $- | $262.29 Million | ▼ -4463 days |
| 2023 | 7109 days | $354.94 Million | $49.93K/day | $- | $354.94 Million | — |